Download Files:
ER 50891
SKU
HY-108531-Get quote
Category Reference compound
Tags Cancer, Metabolic Enzyme/Protease;Vitamin D Related/Nuclear Receptor, RAR/RXR
Products Details
Product Description
– ER-50891 is a potent antagonist of retinoic acid receptor α(RARα). ER-50891 significantly attenuates ATRA’s inhibitive effects on BMP 2-induced osteoblastogenesis[1].
Web ID
– HY-108531
Shipping
– Room temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C29H24N2O2
References
– [1]Batran RZ, et al. New quinolone derivatives as neuropeptide S receptor antagonists: Design, synthesis, homology modeling, dynamic simulations and modulation of Gq/Gs signaling pathways. Bioorg Chem. 2021;111:104817.
CAS Number
– 187400-85-7
Molecular Weight
– 432.51
SMILES
– O=C(O)C1=CC=C(C2=CC=C(C3=NC4=C(C(C)C)C=CC=C4C(C5=CC=CC=C5)=C3)N2)C=C1
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– RAR/RXR
Pathway
– Metabolic Enzyme/Protease;Vitamin D Related/Nuclear Receptor
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.